Chemoinformaics analysis of 1-benzoyloxymethyl-1,6-epoxycyclohexan-2,3,4,5-tetrol
| Molecular Weight | 296.275 | nRot | 3 |
| Heavy Atom Molecular Weight | 280.147 | nRig | 15 |
| Exact Molecular Weight | 296.09 | nRing | 3 |
| Solubility: LogS | -1.611 | nHRing | 1 |
| Solubility: LogP | -0.067 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 39.6627 |
| nHD | 4 | BPOL | 20.3913 |
| QED | 0.393 |
| Synth | 3.905 |
| Natural Product Likeliness | 1.764 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.055 |
| HIA | 0.906 |
| CACO-2 | -5.506 |
| MDCK | 0.00032231 |
| BBB | 0.726 |
| PPB | 0.355688 |
| VDSS | 0.455 |
| FU | 0.532516 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.057 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.124 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.135 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.037 |
| CL | 5.243 |
| T12 | 0.534 |
| hERG | 0.039 |
| Ames | 0.063 |
| ROA | 0.022 |
| SkinSen | 0.038 |
| Carcinogencity | 0.03 |
| EI | 0.008 |
| Respiratory | 0.141 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.731915 |